1Hohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation.N Engl J Med,2009,360:668-678.
2Kφber L,Torp-Pedersen C,McMurray JJ,et al.Increased mortality after dronedarone therapy for severe heart failure.N Engl J Med,2008,358:2678-2687.
3Wazni OM,Marrouche NF,Martin DO,et al.Radiofrequency abla tion vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation:a randomized trial.JAMA,2005,293:2634-2640.
4Ja(I)s P,Cauchemez B,Macle L,et al.Catheter ablation versus anti arrhythmic drugs for atrial fibrillation:the A4 study.Circulation,2008,118:2498-2505.
5Hsu LF,Ja(I)s P,Sanders P,et al.Catheter ablation for atrial fibril lation in congestive heart failure.N Engl J Med,2004,351:2373-2383.
6Pappone C,Rosanio S,Augello G,et al.Mortality,morbidity,and quality of life after circumferential pulmonary vein ablation for atri al fibrillation:outcomes from a controlled nonrandomized long-term study.J Am Coll Cardiol,2003,42:185-197.
7Effect of enalapril on survival in patients with reduced left ventric ular ejection fractions and congestive heart failure.The SOLVD In vestigators.N Engl J Med,1991,325:293-302.
8Vermes E,Tardif JC,Bourassa MG,et al.Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dys function:insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials.Circulation,2003,107:2926-2931.
9Maggioni AP,Anand I,Gottlieb SO,et al.Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.J Am Coll Cardiol,2002,40:1414-1421.
10Maggioni AP,Latini R,Carson PE,et al.Valsartan reduces the incidence of atrial fibrillation in patients with heart failure:results from the Valsartan Heart Failure Trial (Val-HeFT).Am Heart J,2005,149:548-557.
